Skip to main content
Premium Trial:

Request an Annual Quote

Leo Pharma Taps Intomics for Data Services

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bioinformatics contract research firm Intomics will provide its services to Leo Pharma for early drug discovery applications, Intomics said today.

A recent spin-off from The Danish Technical University, Intomics will provide data mining and analysis services for a range of Leo Pharma's research projects.

An independent company owned by the Leo Foundation, Leo Pharma is focused on developing drugs for dermatology and critical care applications, including treatments for psoriasis and other skin diseases, as well as thromboembolisms.

Financial terms of the agreement were not released.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.